Showing results (1351-1360 of 2,454) with videos related to
Sort By:
Pageof 246
BMC Urology|February 3, 2022
Predicting the diagnosis of prostate cancer with a scoring system based on novel biomarkersDurvesh Lachman Jethwani, Lameena Lalitha Sivamoorthy, Charng Chee Toh, et al.BMC Urology|February 17, 2022
Urethrocutaneous fistula following VMMC: a case series from March 2013 to October 2019 in ZAZIC's voluntary medical male circumcision program in ZimbabweVernon Murenje, Victor Omollo, Paidemoyo Gonouya, et al.BMC Urology|February 18, 2022
Perioperative factors influencing the difficulty of retroperitoneal laparoscopic adrenalectomy: a single-center retrospective studyJinyao Wang, Bin Yang, Shiwei Sun, et al.BMC Urology|March 22, 2022
Mirabegron for overactive bladder in frail patients 80 years or over (HOKUTO study)Hiroshi Nakagomi, Takahiko Mitsui, Hiroshi Shimura, et al.BMC Urology|March 25, 2022
Competing risk of the specific mortality among Asian-American patients with prostate cancer: a surveillance, epidemiology, and end results analysisDi Wu, Yaming Yang, Mingjuan Jiang, et al.BMC Urology|April 10, 2022
Eosinophilic cystitis complicated with cystitis glandularis: a case reportJun Bing Ye, Qian Chen, Ke Zeng, et al.BMC Urology|March 29, 2022
A new modified Duckett urethroplasty for repair of proximal hypospadias with severe chordee: outcomes of 133 patientsChong Wang, Zhi-Cheng Zhang, De-Ying Zhang, et al.BMC Urology|September 8, 2018
Number-needed-to-treat analysis of clinical progression in patients with metastatic castration-resistant prostate cancer in the STRIVE and TERRAIN trialsNeil M Schultz, Neal D Shore, Simon Chowdhury, et al.BMC Urology|October 5, 2018
Correction to: Number-needed-to-treat analysis of clinical progression in patients with metastatic castration-resistant prostate cancer in the STRIVE and TERRAIN trialsNeil M Schultz, Neal D Shore, Simon Chowdhury, et al.BMC Urology|March 3, 2022
Salvage robot-assisted radical prostatectomy following focal ablation with irreversible electroporation: feasibility, oncological and functional outcomesAlexandar Blazevski, William Gondoputro, Matthijs J Scheltema, et al.Pageof 246